Title: |
Bendamustine Plus Rituximab Versus CHOP Plus Rituximab in the First-Line-Treatment of Patients with Follicular, Indolent and Mantle Cell Lymphomas: Results of a Randomized Phase III Study of the Study Group Indolent Lymphomas (StiL) |
Source: |
Blood
[0006-4971]
Rummel,
Mathias
yr:2008
|
|
|
|